IL161358A0 - Process for preparing insulin compounds - Google Patents

Process for preparing insulin compounds

Info

Publication number
IL161358A0
IL161358A0 IL16135802A IL16135802A IL161358A0 IL 161358 A0 IL161358 A0 IL 161358A0 IL 16135802 A IL16135802 A IL 16135802A IL 16135802 A IL16135802 A IL 16135802A IL 161358 A0 IL161358 A0 IL 161358A0
Authority
IL
Israel
Prior art keywords
insulin compounds
preparing insulin
compounds
insulin
ester
Prior art date
Application number
IL16135802A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL161358A0 publication Critical patent/IL161358A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL16135802A 2001-11-19 2002-11-15 Process for preparing insulin compounds IL161358A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101716 2001-11-19
PCT/DK2002/000765 WO2003044210A2 (en) 2001-11-19 2002-11-15 Process for preparing insulin compounds

Publications (1)

Publication Number Publication Date
IL161358A0 true IL161358A0 (en) 2004-09-27

Family

ID=8160841

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16135802A IL161358A0 (en) 2001-11-19 2002-11-15 Process for preparing insulin compounds
IL161358A IL161358A (en) 2001-11-19 2004-04-14 Process for preparing insulin compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161358A IL161358A (en) 2001-11-19 2004-04-14 Process for preparing insulin compounds

Country Status (15)

Country Link
EP (1) EP1448786B1 (xx)
JP (1) JP4404631B2 (xx)
KR (1) KR100925381B1 (xx)
CN (1) CN100424179C (xx)
AT (1) ATE464390T1 (xx)
AU (1) AU2002342597A1 (xx)
BR (1) BR0213583A (xx)
CA (1) CA2464616C (xx)
DE (1) DE60236014D1 (xx)
ES (1) ES2344448T3 (xx)
HU (1) HU228934B1 (xx)
IL (2) IL161358A0 (xx)
PL (1) PL210437B1 (xx)
RU (1) RU2376379C2 (xx)
WO (1) WO2003044210A2 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006031955A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
TW200902708A (en) * 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
CA2740685C (en) 2008-10-17 2018-09-11 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a glp-1 agonist
MX346473B (es) * 2009-08-11 2017-03-22 Biocon Ltd Procesos cromatograficos y compuestos purificados de los mismos.
AU2010317995B2 (en) 2009-11-13 2014-04-17 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
JP5973918B2 (ja) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｇｌｐ−１アゴニスト及びメチオニンを含む薬学的組成物
JP6199186B2 (ja) 2010-08-30 2017-09-20 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病の治療用の医薬の製造のためのａｖｅ００１０の使用
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN102703552B (zh) * 2012-05-15 2014-10-29 山东阿华生物药业有限公司 重组人胰岛素的制备方法及其产品
CN102816819B (zh) * 2012-08-13 2014-10-29 山东阿华生物药业有限公司 提高人胰岛素前体融合蛋白酶切转换成b30缺苏氨酸人胰岛素产率的方法
CN103305581B (zh) * 2013-07-04 2015-05-27 珠海联邦制药股份有限公司 一种重组人胰岛素的制备方法
US10611813B2 (en) * 2013-12-23 2020-04-07 Biocon Research Limited Method of production of human insulin methyl ester
HRP20230470T1 (hr) 2014-12-12 2023-07-21 Sanofi-Aventis Deutschland Gmbh Formulacija fiksnog omjera inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
KR20170036643A (ko) * 2015-09-24 2017-04-03 한미약품 주식회사 인슐린의 제조 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE50892B1 (en) 1980-02-11 1986-08-06 Novo Industri As Process for preparing insulin esters
WO1983001074A1 (en) 1981-09-15 1983-03-31 Andresen, Finn, Hede Enzymatic preparation of human insulin or b-30 esters thereof
WO1983000504A1 (en) 1981-08-10 1983-02-17 Andresen, Finn, Hede Enzymatic preparation of human insulin
DK149824C (da) 1982-01-22 1987-03-16 Carlsberg Biotechnology Ltd Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyrer i insuliner
EP0087238A1 (en) 1982-02-08 1983-08-31 Biogen N.V. Am improved method for preparing human insulin from non-human insulin
DK347086D0 (da) 1986-07-21 1986-07-21 Novo Industri As Novel peptides
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
IL84110A (en) * 1986-10-14 1992-11-15 Lilly Co Eli Process for transforming a human insulin precursor to a human insulin
CA1339416C (en) 1987-02-25 1997-09-02 Liselotte Langkjaer Insulin derivatives
US6011007A (en) 1993-09-17 2000-01-04 Novo Nordisk A/S Acylated insulin
RO112873B1 (ro) 1993-09-17 1998-01-30 Novo Nordisk As Derivati de insulina
HUP0203475A3 (en) 1999-12-29 2005-11-28 Novo Nordisk As Method for making insulin precursors and insulin precursor analogs
WO2001049870A1 (en) 1999-12-29 2001-07-12 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
ATE381573T1 (de) 2000-04-14 2008-01-15 Univ Maryland Biotech Inst Verbesserte thermostabilität und temperaturresistenz von proteinen
US20040198960A1 (en) 2001-03-29 2004-10-07 Janoff Edward N Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae

Also Published As

Publication number Publication date
DE60236014D1 (de) 2010-05-27
HUP0500037A3 (en) 2010-01-28
CA2464616A1 (en) 2003-05-30
ATE464390T1 (de) 2010-04-15
CN100424179C (zh) 2008-10-08
KR20050044855A (ko) 2005-05-13
RU2376379C2 (ru) 2009-12-20
CN1589328A (zh) 2005-03-02
WO2003044210A3 (en) 2004-03-25
WO2003044210A2 (en) 2003-05-30
JP4404631B2 (ja) 2010-01-27
ES2344448T3 (es) 2010-08-27
AU2002342597A1 (en) 2003-06-10
IL161358A (en) 2011-05-31
AU2002342597A8 (en) 2003-06-10
CA2464616C (en) 2012-07-24
KR100925381B1 (ko) 2009-11-09
RU2004118503A (ru) 2005-06-10
EP1448786B1 (en) 2010-04-14
HUP0500037A2 (hu) 2005-03-29
EP1448786A2 (en) 2004-08-25
BR0213583A (pt) 2004-08-24
PL369447A1 (en) 2005-04-18
PL210437B1 (pl) 2012-01-31
HU228934B1 (hu) 2013-06-28
JP2005509687A (ja) 2005-04-14

Similar Documents

Publication Publication Date Title
AU2002342597A8 (en) Process for preparing insulin compounds
AU630951B2 (en) Enzymatic removal of a protein amino-terminal sequence
WO2003010187A1 (fr) Procede de production de dipeptides, l-aminoacide amide hydrolase s'utilisant dans ce contexte et procede de production de l-aminoacide amide hydrolase
WO2002012530A8 (en) 3-hydroxycarboxylic acid production and use in branched polymers
EP1013758A3 (en) Novel carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme
AU2002215360A1 (en) Production of alpha-hydroxy-carboxylic acids using a coupled enzyme system
HUP0201152A2 (hu) Eljárás nem proteinogén L-aminosavak előállítására
EP1316613A3 (en) Method for producing optically active mandelic acid derivatives
EP0869128A3 (en) Process for the production of octaphenylcyclotetrasiloxane and sym-tetramethyltetraphenyl cyclotetrasiloxane
EP0896057A3 (en) D-aminoacylase
WO2003095670A3 (en) Process for generating sequence-specific proteases by directed evolution and use thereof
AU3170597A (en) Process for the preparation of amino alcohols and derivatives thereof
EP0927755A3 (en) Haloaccloacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme
AU2002310883A1 (en) Process for the preparation of substituted carboxylic acid estersby enzymatic hydrolysis
HRP20030356A2 (en) Process for enzymatic production of enantiomer-enriched -amino acids
AU2002229706A1 (en) Process for the fermentative production of d-pantothenic acid
IL141284A0 (en) Process for the production of n-protected azetidine-2-carboxylic acids (azeohs)
AU2003244467A1 (en) Process for production of optically active 2-halogeno- carboxylic acids
WO2004081220A3 (en) A process for enzymatically resolving an enantiomeric mixture of alpha-hydroxy acids
TW200516151A (en) Biocatalytic preparation of 1-cyanocyclohexaneacetic acid
EP1382683A3 (en) Process for producing 3-hydroxycyclohexanone
ATE439343T1 (de) Verbessertes verfahren zur zubereitung von gabalactam
AU7677798A (en) Process for the preparation of ampicillin
WO2003048161A8 (fr) Procede pour preparer de la 2,6-dichloropurine
TW200420533A (en) A process for the production of an aqueous solution of adipic acid, hydroxyhexanoic acid and oligomers thereof